secwatch.observer — SEC 8-K summary
======================================

Issuer:     Z Squared Inc. (ZSQR)
CIK:        0001759186
Form:       8-K
Filed at:   2024-12-27T23:59:59+00:00
Accession:  0001683168-24-009012
Event type: other_material
Sentiment:  negative
Materiality: 0.55
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Coeptis Therapeutics proceeds with 1-for-20 reverse stock split; effective after Dec 30
--------------------------------------------------------------------------------

- Reverse split ratio set at 1-for-20; effective after market close Dec 30, post-split trading begins Dec 31.
- No fractional shares issued; fractional holdings rounded up to whole share.
- Split intended to help meet Nasdaq $1.00 minimum bid price requirement.
- Stockholder ownership percentage unchanged except for fractional rounding adjustments.
- CUSIP changes to 19207A 207; par value remains $0.0001.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759186/000168316824009012/0001683168-24-009012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759186/000168316824009012/coeptis_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-009012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer